Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1Phase 2/3 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1

Interventions

Metformin 7empagliflozin 2Tablets 2Letrozole 2Inositol 2Clomiphene 2thymoquinone 1semaglutide 1penclomedine 1chiglitazar 1Vaginal Creams, Foams, and Jellies 1Sitagliptin Phosphate 1Ovidrel 1Folic Acid 1Exenatide 1Curcumin 1Crinone 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Polycystic Ovary Syndrome × Sitagliptin Phosphate × Clear all
NCT05972928 2023-08-02

Effect of Sitagliptin on Polycystic Ovarian Syndrome Patients

Beni-Suef University

Phase 2/3 Unknown
80 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡